We’re a group of passionate professionals from a variety of design-related fields, who have come together to build a purely digital design-focused career accelerator called DESIGNATION. Why design? Because as digital environments become larger and larger parts of our everyday lives, we believe design is more important than ever. Join us, and together we’ll design the future.
Type
Private
HQ
Chicago, US
Founded
2013
Size (employees)
78 (est)+3%
Designation was founded in 2013 and is headquartered in Chicago, US
Report incorrect company information

Key People/Management at Designation

Aaron Fazulak

Aaron Fazulak

CEO | Co-Founder
Aaron Fazulak

Aaron Fazulak

Co-Founder/CEO
Zeke Franco

Zeke Franco

Co-Founder & UX Instructor
Will Shandling

Will Shandling

Director of Communications and Admissions
Zeke Franco

Zeke Franco

UX and IxD Instructor

Designation Office Locations

Designation has offices in Chicago and St. Louis
Chicago, US (HQ)
222 W Merchandise Mart Plaza
Show all (2)
Report incorrect company information

Designation Financials and Metrics

Summary Metrics

Founding Date

2013
Show all financial metrics
Report incorrect company information

Designation News and Updates

BRIEF-Cellectar Granted Orphan Drug Designation For CLR 131

* CELLECTAR GRANTED ORPHAN DRUG DESIGNATION FOR CLR 131 TO TREAT RHABDOMYOSARCOMA Source text for Eikon: Further company coverage:

BRIEF-Acceleron Receives FDA Fast Track Designation For Ace-083 In Facioscapulohumeral Muscular Dystrophy

* ACCELERON RECEIVES FDA FAST TRACK DESIGNATION FOR ACE-083 IN FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY (FSHD) Source text for Eikon: Further company coverage:

BRIEF-Eloxx Pharmaceuticals Announces Orphan-Drug Designation For ELX-02 For Treatment Of Cystinosis

* ELOXX PHARMACEUTICALS ANNOUNCES FDA GRANT OF ORPHAN-DRUG DESIGNATION FOR INVESTIGATIONAL DRUG ELX-02 FOR TREATMENT OF CYSTINOSIS Source text for Eikon: Further company coverage:
Show more
Report incorrect company information